Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate

Information

  • Patent Grant
  • 6933390
  • Patent Number
    6,933,390
  • Date Filed
    Thursday, July 15, 2004
    20 years ago
  • Date Issued
    Tuesday, August 23, 2005
    19 years ago
Abstract
The invention concerns a process for the preparation of N-aryl-aza-heterocycles of the general formula I by reaction of aza-heterocycles with activated aryl halides with use of caesium carbonate without addition of further catalysts at room temperature.
Description
DESCRIPTION

The subject of the invention is process for the nucleophilic substitution on activated aromatics of the general formula XIV
embedded image

in which R1, R2, R3, R4 and R5 are the same or different and signify a hydrogen atom, a nitro group, a cyano group, an alkoxycarbonyl group with up to 5 C-atoms, an aldehyde group, an alkylcarbonyl group with up to 5 C-atoms, an arylcarbonyl group or an amide group whereby the radicals R1 to R5 cannot all simultaneously be a hydrogen atom and HAL stands for a halogen atom but especially for a fluorine atom, with nucleophiles, such as alcohols, amines, sulphoximides, CH-acidic compounds of the formulae V to XI
embedded image

in dipolar aprotic solvents, especially dimethylformamide, with use of caesium carbonate.


The process is preferred for the preparation of compounds of the general formula I
embedded image

in which HETN signifies an aromatic aza-heterocycle with, in all, 5 or 6 ring atoms, whereby up to 3 ring atoms can be nitrogen atoms, and up to two further aromatic carbon rings can be condensed on to the heterocycle and R1 to R5 have the above-mentioned meaning.


Compounds of the general formula I play an important part in medicinal chemistry. Thus, e.g. one finds the N-aryl-aza-heterocyclic structure in substances with anti-oestrogenic (E. Angerer, J. Strohmeier, J. Med. Chem. 30, 131, 1987), with analgesic (E. J. Glamkowski et al., J. Med. Chem. 28, 66, 1985), with anti-diabetic (R. B. Chapleo, G. P. Fagan, Ann. Drug 5 Data Rep. 15, 59, 1993), with anti-miciobial (A. G. Kamat, G. S. Gadaginamath, Indian J. Chem., Sect. B, 33, 255, 1994), with neuroleptic (J. Perregaard et al., J. Med. Chem. 35, 1092, 1.992), with anti-allergic (P. Ungast et al., J. Med. Chem. 32, 1360, 1989), with angiotensin-antagonistic (S. R. Stabler and Jahangir, Syn. Commun. 24, 123, 1994) and with PDGF receptor inhibitory action (Brian D. Palmer et al., J. Med. Chem. 41, 5457, 1998).


Compounds of the general formula I can be prepared according to various methods. A frequently used method consists in the reaction of aza-heterocycles with activated aryl halides in the presence of catalysts and/or bases or, in few cases, also without further additives, according to scheme 1:
embedded image


Thus, e.g. 1-(benzotriazol-1-yl)-2,4-nitro-benzene can be obtained in 96% yield by 9 days boiling of benzotriazole in toluene (A. R. Katritzky, J. Wu, Synthesis 1994, 597).


4-Heterocyclicly-substituted nitrobenzenes and benzaldehydes can be obtained by reaction of the particular aza-heterocycles, such as e.g. benzotriazole, 1,2,4-triazole or benzimidazole, with 4-fluorobenzaldehyde or 4-fluoro- or 4-chlorobenzaldehyde in DMSO or DMF at 100° C. (D. J. Gale, J. F. K. Wilshire, Aust. J. Chem. 23, 1063, 1970; J. Rosevear, J. F. K. Wilshire, Aust. J. Chem. 44, 1097, 1991).


Nitrophenylazoles can be prepared by Ullmann condensation of azoles with aryl halides in pyridine in the presence of potassium carbonate and copper (II) oxide at high temperatures and long reaction times (M. A. Khan, J. B. Polys, J. Chem. Soc. (C), 1970, 85; A. K. Khan, E. K. Rocha, Chem. Pharm. Bull. 25, 3110, 1977) or, however, by reaction of azoles with suitable fluoronitrobenzenes in DMSO at comparatively high temperature and in the presence of potassium carbonate (M. F. Mackay, G. J. Trantino, J. F. Wilshire, Aust. J. Chem. 46, 417, 1993).


1-Arylindoles with activating substituents in the aryl part were obtained by reaction of indole with activated aryl halides in the presence of 37% KF/Al2O3 and catalytic amounts of crown ethers in DMSO at 120° C. (W. J. Smith, J. Scott Sawyer, Tetrahedron Lett. 37, 299, 1996).


There is also described the arylation of azoles with activated aryl halides in the presence of bases, such as caesium carbonate and sodium tert-butylate, whereby, however, the presence of palladium catalyst is additionally necessary and the reaction itself requires high temperature (65° to 120° C.) and long reaction times (3 to 48 hours) (G. Mann, J. F. Hartwig, M. D. Driver, C. Fernandez-Rivas, J. Am. Chem. Soc. 120, 827, 1998; L. P. Beletskaya, D. V. Davydov, M. MorenoManas, Tetrahedron Lett. 39, 5617, 1998).


The use of caesium carbonate as reagent in the case of carbon-heteroatom coupling reactions is also known but further special catalysts must additionally always be used in such reactions (Christopher G. Frost, Paul Mendonca, J. Chem. Soc., Perkin Trans. 1, 1998, 2615).


In general, from the above-given examples, it can be deduced that for arylations of azoles with activated aryl halides, relatively drastic conditions, such as high temperatures, long reaction times, as well as special catalysts, are frequently necessary.


In connection with the synthesis of a potentially anti-cancer compound, the reaction was investigated by use of morpholinopropanol (III) with o-nitrofluorobenzene (II) (scheme 2):
embedded image


Based on our experience with the system caesium carbonate/dimethylformamide for the preparation of carbonates from alcohols and alkyl/aryl halides (DE 199 05 222.0) and of heterocyclic carbamates from aza-heterocycles and alkyl/aryl halides, we investigated whether this system is also suitable for the above reaction.


Surprisingly, it was found that this reaction leads at 23° C. within 48 hours to the desired product (IV) in 82% yield.


On the basis of this finding, it was now investigated whether other nucleophiles, such as e.g. the nucleophiles V to X also react with 2-fluoronitrobenzene at room temperature in the system caesium carbonate/dimethylformamide:
embedded image


It was found that these reactions also give the desired products in good to very good yield at room temperature within 24 to 64 hours. The reaction of 2,5-difluoronitrobenzene (XII) with malonic acid dimethyl ester (XI) at room temperature in the system caesium carbonate/dimethylformamide also leads after 24 hours in 98% yield to the desired product XIII (scheme 3):
embedded image


The preparation of compound XIII is described in the literature with use of sodium hydride in dimethyl sulphoxide at 100° C. in 96% yield (Li Sun et al., J. Med. Chem. 41, 2588, 1998).


Encouraged by these results, the arylation of aza-heterocycles with activated aromatics of the general formula XIV
embedded image

in which R1 to R5 have the above-given meaning and HAL stands for a halogen atom but especially for a fluorine atom, was investigated in the system caesium carbonate/dimethylformamide.


Surprisingly, it was found that almost all azaheterocycles used already react at room temperature in the presence of caesium carbonate/dimethylformamide with activated fluoroaromatics of the general formula XV to give compounds of the general formula I
embedded image


Instead of dimethylformamide, there can also be used other dipolar aprotic solvents, such as e.g. dimethylacetamide, acetonitrile, dimethylsulphoxide, acetone or


N-methylpyrrolidone; however, the reaction times at room temperature are then distinctly longer and the yields often lower.


The process procedure in the case of the preparative carrying out of the arylation is very simple. One dissolves equimolar amounts of azaheterocycle and activated aromatics of the general formula XIV but especially of the general formula XV at room temperature in a suitable dipolar aprotic solvent, especially dimethylformamide, adds thereto a 2 to 4 molar excess of anhydrous caesium carbonate and stirs at room temperature until the reaction is ended. The reaction is monitored by means of thin layer chromatography. In the case of less reactive aromatics, in a few cases the reaction temperature must be increased to about 80° C.


At the end of the reaction, one pours the suspension on to water, extracts the product with ethyl acetate and purifies the product obtained after evaporation of the organic phase with the methods usual in organic chemistry, e.g., by crystallisation or chromatography.







EXAMPLE 1

2-Morpholinopropyloxynitrobenzene


0.57 g 2-fluoronitrobenzene, 0.65 g morpholino-propanol, 3.0 g caesium carbonate and 30 ml dimethylformamide are stirred for 2 days at room temperature in a closed 50 ml round-bottomed flask. One pours the suspension on to 50 ml water, extracts the aqueous phase 3 times with, in each case, 50 ml ethyl acetate and evaporates the combined organic phases on a rotoevaporator. For the removal of the dimethylformamide, which would disturb the chromatographic separation, the DMF-containing residue is again evaporated 2 to 3 times, together with some toluene, at 50° C. and 30 mbar vacuum. The oily residue is then purified on silica gel (0.04 to 0.063 mm) at 0.1 bar by flash chromatography. Once obtains 0.9 g of oil (82.4%).


The following Examples were carried out analogously to Example 1, there are given the following reaction parameters (reaction time/eluent for chromatography/yield/physical statements):


EXAMPLE 2

2-Dimethylaminoethyloxynitrobenzene from 2-fluoronitrobenzene and 2-dimethylaminoethanol


64 h/toluene-ethanol 10+2/91.8%/oil


EXAMPLE 3

2-Dimethylaminopropyloxynitrobenzene from 2-fluoronitrobenzene and 3-dimethylaminopropanol-h/methylene chloride-methanol


10+2/58.7%/oil


EXAMPLE 4

2-(3,3-Diethoxypropoxy)-nitrobenzene from 2-fluoronitrobenzene and 3-hydroxypropionaldehyde diethyl acetal


64 h/hexane-ethyl acetate 10+2/83.7%/oil


EXAMPLE 5

2-Benzyloxynitrobenzene from 2-fluoronitrobenzene and benzyl alcohol 24 h/toluene/95.7%/oil


EXAMPLE 6

2-Benzylaminonitrobenzene from 2-fluoronitrobenzene and benzylamine


64 h/hexane-ethyl acetate 10+2/42.7%/m.p. 74° C.


EXAMPLE 7

4-Fluoro-2-nitrophenylmajonic acid dimethyl ester from 2,5-difluoronitrobenzene and malonic acid dimethyl ester


24 h/toluene-ethanol 10+0.5/98%/oil


EXAMPLE 8

N-2-Nitrophenyldiphenyl sulphoximide from 2-fluoronitrobenzene and diphenyl sulphoximide


48 h/toluene-ethanol 10+2/72%/m.p. 158° C.


EXAMPLE 9

N-2-cyanophenyldiphenyl sulphoximide from 2-fluorobenzonitrile and diphenyl sulphoximide at 80° C.


8 h/toluene-ethanol 10+1/74.3%/m.p. 160° C.


EXAMPLE 10

N-4-Cyanophenyldiphenyl sulphoximide from 4-fluorobenzonitrile and diphenyl sulphoximide


64 h/toluene-ethanol 10+1/61.2%/m.p. 159° C.


EXAMPLE 11

N-4-Nitrophenyldiphenyl sulphoximide from 4-fluoronitrobenzene and diphenyl sulphoximide


64 h/toluene-ethanol 10+0.5/64.1%/m.p. 166° C.


EXAMPLE 12

1-(2-Nitrophenyl)-indole from 2-fluoronitrobenzene and indole


24 h/hexane-ethyl acetate 10+2/90%/81° C.


EXAMPLE 13

1-(4-Cyanophenyl)-pyrrole from 4-fluorobenzonitrile and pyrrole at 80° C.


8 h/toluene/84.11%/05° C.


EXAMPLE 14

1-(4-Cyanophenyl)-pyrrole from 4-fluorobenzonitrile and pyrrole (room temperature)


64 h/toluene/toluene/39.1%/103-104° C.


EXAMPLE 15

1-(4-Cyanophenyl)-indole from 4-fluorobenzonitrile and indole


64 h/toluene-ethanol 10+1/100%/93-94° C.


EXAMPLE 16

1-(4-Ethoxycarbonylphenyl)-indole from 4-fluorobenzoic acid ethyl ester and indole at 80° C.


8 h/hexane-ethyl acetate 10+2/77.2%/m.p. 51° C.


EXAMPLE 17

1-(2-methoxycarbonylphenyl)-indole from 2-fluorobenzoic acid methyl ester and indole


64 h/toluene/20%/oil


EXAMPLE 18

1-(4-Nitrophenyl)-indole from 4-fluoronitrobenzene and indole


64 h/toluene/98%/m.p. 134° C.


EXAMPLE 19

1-(2-Nitrophenyl)-indole-5-carboxylic acid methyl ester from 2-fluoronitrobenzene and indole-5-carboxylic acid methyl ester


64 h/toluene-ethanol 10+1/98%/m.p. 89° C.


EXAMPLE 20

1-(2-nitrophenyl)-indole-3-carboxylic acid methyl ester from 2-fluoronitrobenzene and indole-carboxylic acid methyl ester 24 h/toluene-ethanol 10+1/96%/m.p. 155° C.


EXAMPLE 21

1-(2-Nitrophenyl)-indole-3-carbonitrile from 2-fluoronitrobenzene and indole-3-carbonitrile


24 h/toluene-ethanol 10+1/98%/m.p. 151° C.


EXAMPLE 22

1-(Benzotriazol-1-yl)-2,4-dinitrobenzene from fluoro-2,4-dinitrobenzene and benzotriazole


24 h/toluene-ethanol 10+1/85.5%/m.p. 185° C.


EXAMPLE 23

1-(Benzotriazol-1-yl)-2,4-dinitrobenzene from chloro-2,4-dinitrobenzene and benzotriazole


24 h/toluene-ethanol 10+1/85.5%/m.p. 185° C.


EXAMPLE 24

1-(4-Nitrophenyl)-indole-3-aldehyde from 4-fluoronitrobenzene and indole-3-aldehyde


24 h/crystallisation in the case of working up/91.6%/m.p. 269° C.


EXAMPLE 25

1-(4-Formylphenyl)-indole from 4-fluorobenzaldehyde and indole


48 h/toluene/7.7%/oil


EXAMPLE 26

1-(2-Methoxycarbonylphenyl)-indole from 2-fluorobenzoic acid methyl ester and indole at 80° C.


8 h/hexane-ethyl acetate 10+2/19.4%/oil


EXAMPLE 27

5-Methyl-1-(4-nitrophenyl)-indole from 4-fluoronitrobenzene and 5-methylindole


24 h/toluene/77.3%/m.p. 147° C.


EXAMPLE 28

5-Nitro-1-(4-nitrophenyl)-indole from 4-fluoronitrobenzene and 5-nitroindole


24 h/crystallisation in the case of working up/86.9%/m.p. 235° C.


EXAMPLE 29

5-Chloro-1-(2-nitrophenyl)-indole from 2-fluoronitrobenzene and 5-chloroindole


24 h/toluene/71.5%/m.p. 142° C.


EXAMPLE 30

5-Methoxy-L-(2-cyanophenyl)-indole from 2-fluorobenzonitrile and 5-methoxyindole


3 h/toluene/100%/m.p. 99° C.


EXAMPLE 31

1-(2-Nitrophenyl)-pyrrole from 2-fluoronitrobenzene and pyrrole


64 h/hexane-ethyl acetate 10+2/68.6%/m.p. 105° C.


EXAMPLE 32

5-Methoxy-1-(4-nitrophenyl)-indole from 4-chloronitrobenzene and 5-methoxyindole at 80° C.


8 h/toluene/27.2%/m.p. 187° C.


EXAMPLE 33

3-Methyl-1-(4-nitrophenyl)-indole from 4-fluoronitrobenzene and 3-methylindole


24 h/toluene/84.1%/m.p. 146° C.


EXAMPLE 34

5-Methoxy-1-(4-ethoxycarbonylphenyl)-indole from 4-fluorobenzoic acid ethyl ester and 5-methoxyindole at 80° C.


8 h/hexane-ethyl acetate 10+2/68.5%/oil


EXAMPLE 35

5-Methoxy-1-(4-nitrophenyl)-indole from 4-fluoronitrobenzene and 5-methoxyindole


18 h/crystallisation in the case of working up/88.1%/5 m.p. 188° C.


EXAMPLE 36

1-(2-Nitrophenyl)-indole-2-carboxylic acid ethyl ester from 2-fluoronitrobenzene and indole-2-carboxylic acid ethyl ester


58 h/toluene/47.9%/m.p. 90° C.


EXAMPLE 37

1-(4-Nitrophenyl)-indole-2-carboxylic acid ethyl ester from 4-fluoronitrobenzene and indole-2-carboxylic acid ethyl ester at 8° C.


8 h/toluene/78.5%/m.p. 135° C.


EXAMPLE 38

1-(3-Nitrophenyl)-indole from 3-fluoronitrobenzene and indole at 80° C.


6 h/hexane-ethyl acetate 10+2/72.9%/m.p. 66° C.


EXAMPLE 39

1-(3-Cyanophenyl)-indole from 3-fluorobenzonitrile and indole at 80° C.


8 h/toluene-ethanol 10+1/55.8%/m.p. 37° C.


EXAMPLE 40

1-(2-Cyanophenyl)-indole from 2-fluorobenzonitrile and indole


64 h/toluene/100%/m.p. 112° C.


EXAMPLE 41

1-(2-Nitrophenyl)-imidazole from 2-fluoronitrobenzene and imidazole


18 h/toluene-ethanol 10+2/92%/m.p. 980-99° C.


EXAMPLE 42

1-(2-Nitrophenyl)-benzimidazole from 2-fluoronitrobenzene and benzimidazole


18 h/toluene-ethanol 10+2/98.8%/oil


EXAMPLE 43

1-(4-Nitrophenyl)-indazole from 4-fluoronitrobenzene and indazole


18 h/crystallisation in the case of working up/92%/m.p. 166° C.


EXAMPLE 44

N-2,4-dibitrophenylcarbazole from 2,4-dinitrofluorobenzene and carbazole


18 h/crystallisation in the case of working up/m.p. 189° C.


EXAMPLE 45

1-(2-cyanophenyl)-1,2,3-triazole from 2-fluorobenzonitrile and 1,2,3-triazole


24 h/toluene-ethanol 10+1/14.2%/m.p. 112° C.


EXAMPLE 46

4-(4-cyanophenyl)-1,2,4-triazole from 4-fluorobenzonitrile and 1,2,4-triazole


24 h/toluene-ethanol 10+2/14.2%/m.p. 169° C.


EXAMPLE 47

5-chloro-1-(2-cyanophenyl)-indole from 2-fluorobenzonitrile and 5-chloroindole


24 h/toluene/70.4%/m.p. 129-130° C.


EXAMPLE 48

1-(2-pyridyl)-indole from 2-fluoropyridine and indole at 80° C.


24 h/toluene/84.1%/m.p. 58° C.

Claims
  • 1. A process for preparing compounds of general formula I,
  • 2. The process according to claim 1, characterized in that the solvent is acetone, acetonitrile, dimethylsulphoxide, dimethylacetamide, N-methylpyrrolidone or dimethylformamide.
  • 3. The process according to claim 1, characterized in that the solvent is dimethylformamide.
  • 4. The process according to claim 1, characterized in the HAL in general formula XIV is a fluorine atom.
  • 5. The process according to claim 1, wherein the aromatic aza-heterocycle and the compound of general formula XIV are reacted at room temperature.
Priority Claims (1)
Number Date Country Kind
199 14 610 Mar 1999 DE national
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. Application No. 09/889,341, filed Feb. 7, 2002, now U.S. Pat. No. 6,774,242, which was the National Stage of International Application No. PCT/EP00/01574 filed Feb. 25, 2000.

US Referenced Citations (1)
Number Name Date Kind
5977361 Hartwig et al. Nov 1999 A
Related Publications (1)
Number Date Country
20040249185 A1 Dec 2004 US
Divisions (1)
Number Date Country
Parent 09889341 US
Child 10892422 US